Effects of Aromatherapy for Older Adults at Risk of Metabolic Syndrome in the Community

NCT05987020 | Unknown

• 1 other identifier: Mei-Hui Wang
• Study Type: interventional
• Target: 64
• Locations: 1 country
• Sites: 1

Brief Summary

Background: According to statistics, Taiwan will become a super-aged society in 2025, and health promotion and care for the elderly are important issues of public health. With the prolongation of life, the older adults need to face their physical weakness, decline in psychological, cognitive and social related functional abilities, the prevalence of chronic diseases and the increase in the disabled population, which has a considerable impact on individuals, families and the overall social economy. However, most older adults suffering from chronic diseases are often accompanied by physical dysfunction, which affects the quality of sleep, causes emotional distress and emotional disorders, and leads to a decline in the quality of life. Studies have found that aromatherapy can not only improve sleep and emotional problems, but also relieve physical discomfort caused by diseases, achieve the purpose of reducing medical costs and improving quality of life. However, there are very few studies regrading older adults who are at risk of metabolic syndrome in community and the effects of inhalation of compound essential oils on their sleep and quality of life. Therefore, this study will explore the use of aromatherapy to improve the quality of sleep and life of the elderly. The research results can be used as a reference for community bases to promote the improvement of sleep and quality of life for older adults, so as to achieve the goal of healthy aging.

Conditions

Metabolic Syndrome

Keywords

Aromatherapy; Older Adults at Risk of metabolic syndrome; quality of life; quality of sleep

Outcome Measures

Primary Outcomes (2)

• The quality of sleep of elderly people at risk of metabolic syndrome in community bases participating in aromatherapy

  Basic Demographic Information", " The Chinese version of the Pittsburgh Sleep Quality Index, CPSQI

  1 month after intervention

• The quality of life of elderly people at risk of metabolic syndrome in community bases participating in aromatherapy

  Basic Demographic Information","The World Health Organization Quality of Life Questionnaire -Taiwan Version" and ""The World Health Organization Quality of Life Questionnaire -old".

  1 month after intervention

Study Arms (2)

pre-specified group

EXPERIMENTAL

The experimental group received "aromatherapy", an intervention using lavender essential oil compound, while the control group received a placebo, sweet almond oil. The research tools include: "Basic Demographic Information", " The Chinese version of the Pittsburgh Sleep Quality Index, CPSQI ", "The World Health Organization Quality of Life Questionnaire -Taiwan Version" and ""The World Health Organization Quality of Life Questionnaire -old".

Other: Aromatherapy

subgroup of participant

PLACEBO COMPARATOR

The control group received a placebo, sweet almond oil. The research tools include: "Basic Demographic Information", " The Chinese version of the Pittsburgh Sleep Quality Index, CPSQI ", "The World Health Organization Quality of Life Questionnaire -Taiwan Version" and ""The World Health Organization Quality of Life Questionnaire -old".

Other: Aromatherapy

Interventions

Aromatherapy OTHER

The experimental group received "aromatherapy", an intervention using lavender essential oil compound, while the control group received a placebo, sweet almond oil.

pre-specified group; subgroup of participant

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• Students aged 65 or above in community care bases 2. People with normal sense of smell 3. No severe respiratory disease 4. Have any one of the metabolic syndrome risk factors
• According to the definition of the National Health Service:
• Abdominal obesity: waist circumference ≧90cm for men, waist circumference ≧80cm for women;
• High blood pressure: systolic blood pressure ≧ 130mmHg or diastolic blood pressure ≧ 85mmHg, or taking medication for hypertension prescribed by a doctor;
• High fasting blood sugar: fasting blood sugar ≧100mg/dL, or taking a doctor's prescription for diabetes treatment;
• High fasting triglycerides: ≧150mg/dL, or taking medicines for lowering triglycerides prescribed by doctors;
• Low high-density lipoprotein cholesterol: men \<40mg/dL, women \<50mg/dL, the above five items are risk factors, and three or more items are met as metabolic syndrome.
• \. Complaints of sleep disorders 6. Those who agree and can cooperate with research activities

You may not qualify if:

• Those who are allergic to essential oils
• Diagnosed with dementia, mental illness: such as depression
• Cancer patients
• Those who are currently using aromatherapy/have participated in or used aromatherapy-related activities within one month
• Currently there is a wound on the shoulder and neck

Sponsors & Collaborators

• National Taipei University of Nursing and Health Sciences: lead

Study Sites (1)

Hsinchu Cathay General Hospital

Hsinchu, East Dist, 300, Taiwan

RECRUITING

MeSH Terms

Conditions

Metabolic Syndrome; Sleep Initiation and Maintenance Disorders

Interventions

Aromatherapy

Condition Hierarchy (Ancestors)

Insulin Resistance; Hyperinsulinism; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases; Mental Disorders

Intervention Hierarchy (Ancestors)

Mind-Body Therapies; Complementary Therapies; Therapeutics; Phytotherapy; Sensory Art Therapies; Psychotherapy; Behavioral Disciplines and Activities

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: single blinding
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Head nurse

Model Details: randomized controlled trial，RCT

Study Record Dates

• First Submitted: July 27, 2023
• First Posted: August 14, 2023
• Study Start: September 19, 2023
• Primary Completion: November 8, 2023
• Study Completion: April 30, 2024
• Last Updated: November 9, 2023

Record last verified: 2023-11

Data Sharing

• IPD Sharing: Will not share

Locations

TW (1)